PA
HOOK

Parallel Advisors’s HOOKIPA Pharma HOOK Stock Holding History

Parallel Advisors’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-35
Closed -$70 – 3580
2024
Q4 		$70 Hold
35
– – ﹤0.01% 3465
2024
Q3 		$151 Hold
35
– – ﹤0.01% 3319
2024
Q2 		$207 Buy
+35
New +$278 ﹤0.01% 3199

Other funds holding HOOK

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Parallel Advisors's HOOK Position: Q1 2025 in Review

Parallel Advisors sold out of HOOKIPA Pharma (HOOK) in Q1 2025, closing a stake of 35 shares — an estimated $70 sold.

Parallel Advisors first reported a position in HOOK in Q2 2024 and held it in 3 quarters. The position peaked at $207 in Q2 2024. 32 funds tracked by Wall St. Rank hold HOOK as of Q1 2025.

  • Parallel Advisors reported no remaining HOOKIPA Pharma position as of Q1 2025 after selling out during the quarter.
  • Parallel Advisors sold 35 HOOKIPA Pharma shares in Q1 2025, an estimated $70.
  • Parallel Advisors first reported a position in HOOKIPA Pharma in Q2 2024 and held it in 3 quarters.
  • Parallel Advisors's HOOKIPA Pharma position peaked at $207 in Q2 2024.
  • 32 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2025.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.